AJMC December 19, 2021
Physicians said it is in payers’ interest to use artificial intelligence to address social determinants of health, to cover tests, and to gather data. Doing so could let them stratify who needs certain screenings and diagnostic procedures and who doesn’t, which could lead to less consumption of health care.
At one point in the discussion, “Precision Medicine: Innovation in Testing and Technology,” moderator Joseph Alvarnas, MD, noted that the 2 most recent American Cancer Society reports on survival had shown the largest drops in mortality ever recorded.1 This was due to the rise of genomic-informed targeted therapeutics, particularly in non–small cell lung cancer, which accounts for the largest share of cancer deaths.
The question, said Alvarnas, a cochair for Patient-Centered...
Today's Sponsors
Today's Sponsor